Dr. Reddy's Laboratories share price closes at ₹1,145 on September 9
Last Updated: 9th September 2026 - 06:24 pm
Key Takeaways
- Dr. Reddy's Laboratories fell ₹6 or 0.52% to ₹1,145.
- The session covered ₹15 between ₹1,136 and ₹1,151.
- The close was ₹53 below the 50-day DMA.
- The stock's one-month return stood at -2.30%.
Dr. Reddy's Share Price Laboratories closed at ₹1,145 on September 9, down ₹6 or 0.52% from the preceding close of ₹1,151. The opening price was ₹1,146, just ₹1 above where the share ultimately finished. This left the open-to-close movement much smaller than the full session range.
The day's high was ₹1,151, identical to the previous close, while the low was ₹1,136. The ₹15 gap between those two levels defined the intraday range. The stock finished ₹6 below the high and ₹9 above the low. From the opening price, the maximum upward move was ₹5 and the downward move was ₹10.
The 50-day DMA stood at ₹1,198 and the 200-day DMA at ₹1,241.90. The September 9 close was ₹53 below the shorter average and ₹96.90 below the longer one. The 200-day DMA exceeded the 50-day DMA by ₹43.90.
Volume came in at 553,404 shares. Over 52 weeks, Dr. Reddy's traded between ₹1,101 and ₹1,415, creating a ₹314 span. The closing price was ₹44 above the annual low and ₹270 below the high. Market capitalisation was around ₹96,113 crore.
The one-month return stood at -2.30%, while three months showed -10.24%. The six-month figure was -12.18%, and the one-year return was -8.44%. The one-month number was therefore 9.88 percentage points above the six-month reading, while the one-year and three-month figures were separated by 1.80 percentage points.
Frequently Asked Questions
What was Dr. Reddy's Laboratories' closing price?
What was the stock's September 9 low?
How far was the close from the 52-week low?
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.
5paisa Capital Ltd